Overview
Tetsuo Omachi practices in Shizuoka, Japan. Mr. Omachi is rated as an Experienced expert by MediFind in the treatment of Retinoblastoma. His top areas of expertise are Merkel Cell Carcinoma, Neuroendocrine Tumor, Leydig Cell Testicular Tumor, and Sertoli-Leydig Cell Tumor.
His clinical research consists of co-authoring 11 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Retinoblastoma.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Merkel Cell CarcinomaMr. Omachi isAdvanced. Learn about Merkel Cell Carcinoma.
- Experienced
- Leydig Cell Testicular TumorMr. Omachi isExperienced. Learn about Leydig Cell Testicular Tumor.
- Neuroendocrine TumorMr. Omachi isExperienced. Learn about Neuroendocrine Tumor.
- RetinoblastomaMr. Omachi isExperienced. Learn about Retinoblastoma.
- Sertoli-Leydig Cell TumorMr. Omachi isExperienced. Learn about Sertoli-Leydig Cell Tumor.